• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15922 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2011 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Bioabsorbable everolimus-eluting coronary stent (BVS) for treatment of coronary artery disease]
2011 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Dissemination of HTA products. New lines of action]
2011 Penn Medicine Center for Evidence-based Practice (CEP) Tests for early diagnosis of sepsis
2011 Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for management of sepsis
2011 Penn Medicine Center for Evidence-based Practice (CEP) Impact of retracted articles on the evidence base for hydroxyethyl starch
2011 Penn Medicine Center for Evidence-based Practice (CEP) Tunneled vs. non-tunneled catheters for acute hemodialysis
2011 Penn Medicine Center for Evidence-based Practice (CEP) Active management and treatment of postpartum hemorrhage
2011 Penn Medicine Center for Evidence-based Practice (CEP) Risk factors for hospital readmission
2011 Penn Medicine Center for Evidence-based Practice (CEP) Femoral closure devices for cardiac catheterization
2011 Penn Medicine Center for Evidence-based Practice (CEP) Transradial access for cardiac catheterization
2011 Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for verifying Dobbhoff tube placement
2011 Agency for Healthcare Research and Quality (AHRQ) Values of older adults related to primary and secondary prevention
2011 Agency for Healthcare Research and Quality (AHRQ) Screening for hearing loss in adults ages 50 years and older: a review of the evidence for the U.S. Preventive Services Task Force.
2011 Agency for Healthcare Research and Quality (AHRQ) Behavioral counseling to prevent skin cancer: systematic evidence review to update the 2003 U.S. Preventive Services Task Force Recommendation
2011 Agency for Healthcare Research and Quality (AHRQ) Screening for visual impairment in children ages 1-5 years: systematic review to update the 2004 U.S. Preventive Services Task Force Recommendation
2011 Agency for Healthcare Research and Quality (AHRQ) Traumatic brain injury and depression.
2011 Agency for Healthcare Research and Quality (AHRQ) Pain management interventions for hip fracture
2011 Medical Services Advisory Committee (MSAC) Brachytherapy for the treatment of prostate cancer
2011 Medical Services Advisory Committee (MSAC) Review of kyphoplasty for the treatment of vertebral compression fracture and review of interim funded service: vertebroplasty for the treatment of vertebral compression fracture
2011 Medical Services Advisory Committee (MSAC) Genetic testing for hereditary mutation of the von Hippel-Lindau (VHL) gene
2011 Medical Services Advisory Committee (MSAC) Diagnostic use of thyrotropin alfa-rch for patients with well-differentiated thyroid cancer
2011 The Swedish Council on Health Technology Assessment (SBU) [Laser-induced interstitial thermal therapy for liver metastases]
2011 Health Council of the Netherlands Gezondheidsraad (GR) [Fair compensation. Consideration of a proposal to give live kidney donors priority for transplants]
2011 Andalusian Health Technology Assessment Area (AETSA) [Analysis of health and socioeconomic factors influencing the progressive increase in frequentation of hospital emergency services]
2011 Andalusian Health Technology Assessment Area (AETSA) [Inclusion of new health technologies into Spanish hospitals]
2011 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation
2011 NIHR Health Technology Assessment programme Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review
2011 NIHR Health Technology Assessment programme Hemiarthroplasty and total hip arthroplasty for treating primary intracapsular fracture of the hip: a systematic review and cost-effectiveness analysis
2011 NIHR Health Technology Assessment programme A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis
2011 NIHR Health Technology Assessment programme Liraglutide for the treatment of type 2 diabetes
2011 NIHR Health Technology Assessment programme Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura
2011 NIHR Health Technology Assessment programme Golimumab for the treatment of ankylosing spondylitis
2011 NIHR Health Technology Assessment programme Retigabine for the adjunctive treatment of adults with partial onset seizures in epilepsy with and without secondary generalisation
2011 NIHR Health Technology Assessment programme Bivalirudin for the treatment of ST-segment elevation myocardial infarction
2011 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation
2011 NIHR Health Technology Assessment programme Ticagrelor for the treatment of acute coronary syndromes
2011 NIHR Health Technology Assessment programme Eribulin for the treatment of locally advanced or metastatic breast cancer
2011 NIHR Health Technology Assessment programme Fingolimod for the treatment of relapsing remitting multiple sclerosis
2011 NIHR Health Technology Assessment programme Tocilizumab for the treatment of systemic juvenile idiopathic arthritis
2011 NIHR Health Technology Assessment programme Denosumab for osteoporotic fractures in post menopausal women primary and secondary prevention
2011 NIHR Health Technology Assessment programme Erlotinib monotherapy for the maintenance treatment of non-small cell lung cancer after previous platinum-containing therapy
2011 NIHR Health Technology Assessment programme Mannitol dry powder for inhalation for the treatment of cystic fibrosis
2011 NIHR Health Technology Assessment programme Belimumab for the treatment of active autoantibody-positive systemic lupus erythematosus
2011 NIHR Health Technology Assessment programme Fulvestrant for the treatment of locally advanced or metastatic breast cancer
2011 NIHR Health Technology Assessment programme Ofatumumab for the treatment of chronic lymphocytic leukaemia in patients who are refractory to fludarabine and alemtuzumab: a critique of the submission from GSK
2011 NIHR Health Technology Assessment programme Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11
2011 NIHR Health Technology Assessment programme Ranibizumab for the treatment of macular oedema caused by retinal vein occlusion (RVO): a single technology appraisal
2011 NIHR Health Technology Assessment programme Trabectedin for the treatment of relapsed ovarian cancer
2011 NIHR Health Technology Assessment programme Roflumilast for the management of severe chronic obstructive pulmonary disease
2011 NIHR Health Technology Assessment programme Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction
2011 NIHR Health Technology Assessment programme Bevacizumab in combination with a taxane for the first-line treatment of HER2-negative metastatic breast cancer
2011 NIHR Health Technology Assessment programme A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease
2011 NIHR Health Technology Assessment programme Prucalopride for the treatment of chronic constipation in women in whom laxatives fail to provide adequate relief
2011 NIHR Health Technology Assessment programme Golimumab for the treatment of psoriatic arthritis
2011 Belgian Health Care Knowledge Centre (KCE) Transcatheter aortic valve implantation (TAVI): an updated health technology assessment
2011 HAYES, Inc. Acticoat (Smith&Nephew Inc.) for Burn Wounds
2011 HAYES, Inc. Antibacterial suture for prevention of infection
2011 HAYES, Inc. Bipolar plasmakinetic electrovaporization for benign prostatic hyperplasia (BPH)
2011 HAYES, Inc. Endoscopic cyclophotocoagulation for glaucoma
2011 HAYES, Inc. Intermittent pneumatic compression therapy for mastectomy-related lymphedema
2011 HAYES, Inc. Intrauterine balloon tamponade for the management of postpartum hemorrhage
2011 HAYES, Inc. Intravenous ketamine for chronic nonmalignant pain
2011 HAYES, Inc. Near-infrared spectroscopy (INVOS cerebral/somatic oximeter) (Covidien) for adult cerebral indications
2011 HAYES, Inc. Neutralizing Antibody (NAb) testing using the myxovirus protein A (MxA) assay to assess interferon beta treatment of multiple sclerosis
2011 HAYES, Inc. On-X prosthetic heart valve (On-X Life Technologies Inc.) for cardiac valve replacement
2011 NIHR Health Technology Assessment programme Ranibizumab for the treatment of diabetic macular oedema
2011 HAYES, Inc. Promacta (eltrombopag) tablets (GlaxoSmithKline) for chronic idiopathic thrombocytopenic purpura (ITP)
2011 HAYES, Inc. Rituxan (Rituximab) (Genentech Inc. and Biogen Idec Inc.) for Chronic Lymphocytic Leukemia(CLL)
2011 HAYES, Inc. SprayShield adhesion barrier system (Covidien Inc.) for prevention of postoperative adhesions
2011 HAYES, Inc. Topaz MicroDebrider (ArthroCare Corp.) for treatment of tendon disorders of the upper extremities
2011 HAYES, Inc. Previstage GCC colorectal cancer staging test
2011 HAYES, Inc. Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS; Familial Hibernian Fever)
2011 HAYES, Inc. Brachytherapy for breast cancer
2011 HAYES, Inc. Cognitive-behavioral therapy for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in adults
2011 HAYES, Inc. Full-field digital mammography for breast cancer screening
2011 HAYES, Inc. Lipoprotein-associated phospholipase testing for stroke assessment in adults
2011 HAYES, Inc. Minimally invasive total hip arthroplasty
2011 HAYES, Inc. Nicotine replacement therapy for smoking cessation: nicotine gum and nicotine lozenge
2011 HAYES, Inc. Nicotine replacement therapy for smoking cessation: nicotine nasal spray and nicotine inhaler
2011 HAYES, Inc. Nicotine replacement therapy for smoking cessation: nicotine patch
2011 HAYES, Inc. NovoSeven coagulation factor VIIa (recombinant) for prevention and control of bleeding in patients without hemophilia
2011 HAYES, Inc. Osteopathic Manipulative Treatment (OMT) for back pain
2011 HAYES, Inc. Photographic surveillance for early detection of malignant melanoma
2011 HAYES, Inc. Platelet-rich plasma for ligament and tendon injuries
2011 HAYES, Inc. Positron Emission Tomography (PET) for alzheimer's disease
2011 HAYES, Inc. Radiofrequency ablation of the pulmonary veins for the treatment of atrial fibrillation
2011 HAYES, Inc. Transvaginal ultrasound for measurement of cervical length to predict preterm birth
2011 The Swedish Council on Health Technology Assessment (SBU) [Peripherally Inserted Central Venous Catheter (PICC)]
2011 The Swedish Council on Health Technology Assessment (SBU) [Vacuum assisted wound closure therapy]
2011 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Bioimpedance vector analysis in the assessment of nutritional status and body fluid volume in patients with chronic renal failure]
2011 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [ReWalk(tm): motorized orthosis in wheelchair users paraplegic people]
2011 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Hypothermia therapy for treatment of neonatal hypoxic-ischemic encephalopathy]
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Pre-operative skin preparation solutions: a review of the evidence on safety
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) MAKO's RESTORIS implants and MAKOplasty procedure for early to mid-stage osteoarthritic knee disease: a review of the clinical and cost-effectiveness and safety
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Blood pressure monitoring chairs to identify hypertension: a review of the clinical effectiveness and guidelines
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Interferon-gamma release assays testing versus tuberculosis skin testing for tuberculosis: a review of the clinical effectiveness and guidelines
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Point of care cholesterol testing for coronary heart disease: a review of the clinical effectiveness and guidelines
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Disposable gloves for use in healthcare settings: a review of the clinical effectiveness, safety, cost-effectiveness, and guidelines
2011 Canadian Agency for Drugs and Technologies in Health (CADTH) Mycophenolate mofetil tablets for uveitis: a review of the comparative clinical and cost-effectiveness